About this trial
Objective This study aims to evaluate the safety and efficacy of antegrade flexible ureteroscopy-assisted PCNL for the treatment of staghorn calculi, compared with standard PCNL.
Methods This prospective, multicenter, randomized controlled trial plans to enroll 420 patients with staghorn calculi, randomly assigned into two groups: the experimental group (antegrade flexible ureteroscopy-assisted PCNL, n=210) and the control group (standard PCNL, n=210). The primary endpoint is stone-free rate (defined as no residual fragment ≥2 mm on postoperative CT). Secondary endpoints include operative time, number of percutaneous tracts, rate of secondary procedures, hemoglobin decrease, postoperative complications (Clavien-Dindo classification), and length of hospital stay. All patients will undergo CT evaluation on postoperative day 2. Subgroup analysis will be performed according to the number of stone branches (≥5 vs \<5).
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- antegrade flexible ureteroscopy-assisted PCNL
- single PCNL
Treatment groups
Locations
Sponsors and collaborators
Tianjin Medical University Second Hospital
Lead sponsor
Chinese PLA General Hospital
Collaborator
Tianjin Medical University General Hospital
Collaborator
Peking University People's Hospital
Collaborator
First Hospital of China Medical University
Collaborator
The Second Affiliated Hospital of Dalian Medical University
Collaborator
The First Affiliated Hospital of Guangzhou Medical University
Collaborator
Second Affiliated Hospital of Guangzhou Medical University
Collaborator
The First Affiliated Hospital with Nanjing Medical University
Collaborator
Beijing Tsinghua Changgeng Hospital
Collaborator
The First Affiliated Hospital of Soochow University
Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborator
The Affiliated Hospital of Qingdao University
Collaborator
Wuhan TongJi Hospital
Collaborator